Prevalence and incidence in patients with autoimmune rheumatic diseases: A nationwide population-based study in Taiwan

Arthritis Care and Research

Volumn 65, Issue 2, 2013, Pages 244-250

  Yu, Kuang Hui ^a   See, Lai Chu ^a   Kuo, Chang Fu ^a   Chou, I Jun ^a   Chou, Meng Jiun ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; DERMATOMYOSITIS; FEMALE; HEALTH INSURANCE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMYOSITIS; POPULATION RESEARCH; PREVALENCE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; STANDARDIZED MORTALITY RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TAIWAN; VASCULITIS;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; PREVALENCE; REGISTRIES; RHEUMATIC DISEASES; TAIWAN;

EID: 84873122473     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21820     Document Type: Article

References (53)

1. Walsh SJ, Rau LM,. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000; 90: 1463-6.
2. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25.
3. Jacobson DL, Gange SJ, Rose NR, Graham NM,. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
4. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH,. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, and rural differences. J Rheumatol 1994; 21: 302-6.
5. Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, et al. Rheumatic diseases in China. Arthritis Res Ther 2008; 10: R17.
6. Bernatsky S, Lix L, Hanly JG, Hudson M, Badley E, Peschken C, et al. Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int 2010; 31: 549-54.
7. Gabriel SE, Michaud K,. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229.
8. Cooper GS, Bynum ML, Somers EC,. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009; 33: 197-207.
9. Fanchiang C,. New IC health insurance card expected to offer many benefits. Taiwan J 2004. URL: www.taiwantoday.tw/ct.asp?xItem=20439&CtNode= 122.
10. National Health Insurance Research Database. 2010. URL: http://w3.nhri.org.tw/nhird//date-01.html.
11. Lu TH, Lee MC, Chou MC,. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 2000; 29: 336-43.
12. Ulm K,. A simple method to calculate the confidence interval of a standardised mortality ratio. Am J Epidemiol 1990; 131: 373-5.
13. Alamanos Y, Voulgari PV, Drosos AA,. Rheumatoid arthritis in Southern Europe: epidemiological, clinical, radiological and genetic considerations. Curr Rheum Rev 2005; 1: 33-6.
14. Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS,. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010; 39: 257-68.
15. Tobon GJ, Youinou P, Saraux A,. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010; 35: 10-4.
16. Spector TD,. Rheumatoid arthritis. Rheum Dis Clin North Am 1990; 16: 513-37.
17. Peschken CA, Esdaile JM,. Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum 1999; 28: 368-91.
18. Kuo CF, Luo SF, See LC, Chou IJ, Chang HC, Yu KH,. Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int 2012. E-pub ahead of print.
19. Chiu YM, Lai CH,. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 2010; 19: 1250-5.
20. Petri M,. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002; 16: 847-58.
21. Ward MM,. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the Third National Health and Nutrition Examination Survey. J Womens Health 2004; 13: 713-8.
22. Xu D, Li B, Chen H, Ruan Z, Zeng Y, Yang X,. Epidemiological study of systemic lupus erythematosus in Guangzhou area. Chin J Dermatol 1992; 25: 50-2. In Chinese.
23. Jiang B, Zhang Y, Xu X, Mei H, Wang G, Ding E, et al. A prevalence study of rheumatic diseases in eastern coastline of Shandong province. Acta Acad Med Shandong 2001; 39: 210-1.
24. Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT,. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 2152-8.
25. Mok CC, To CH, Ho LY, Yu KL,. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 2008; 35: 1978-82.
26. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-7.
27. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778-99.
28. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-55.
29. Bernatsky S, Joseph L, Pineau CA, Belisle P, Hudson M, Clarke AE, et al. Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 2009; 61: 400-4.
30. Bryan C, Howard Y, Brennan P, Black C, Silman A,. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996; 35: 1122-6.
31. Walsh SJ, Fenster JR,. Geographical clustering of mortality from systemic sclerosis in the Southeastern United States, 1981-90. J Rheumatol 1997; 24: 2348-52.
32. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR,. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004; 33: 39-43.
33. Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ III, O'Fallon WM, et al. Incidence of physician-diagnosed primary Sjögren's syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001; 76: 593-9.
34. Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, et al. Prevalence of primary Sjögren's syndrome in China. J Rheumatol 1995; 22: 659-61.
35. Voulgarelis M, Tzioufas AG, Moutsopoulos HM,. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008; 26 Suppl 51: S66-71.
36. Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D, et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex, and regional differences. Ann Rheum Dis 2009; 68: 1192-6.
37. Choy EH, Isenberg DA,. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 2002; 41: 7-13.
38. Bendewald MJ, Wetter DA, Li X, Davis MD,. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol 2010; 146: 26-30.
39. Airio A, Kautiainen H, Hakala M,. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006; 25: 234-9.
40. Limaye V, Hakendorf P, Woodman RJ, Blumbergs P, Roberts-Thomson P,. Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Intern Med J 2012; 42: 191-8.
41. Lane SE, Watts R, Scott DG,. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 2005; 7: 270-5.
42. Watts RA, Lane SE, Bentham G, Scott DG,. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000; 43: 414-9.
43. Gonzalez-Gay MA, Garcia-Porrua C,. Systemic vasculitis in adults in North Western Spain 1988-97. Medicine (Baltimore) 1999; 78: 292-308.
44. Tidman M, Olander R, Svalander C, Danielsson D,. Patients hospitalised because of small vessel vasculitis with renal involvement in the period 1975-95: organ involvement, antineutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244: 133-41.
45. El-Reshaid K, Kapoor MM, el-Reshaid W, Madda JP, Varro J,. The spectrum of renal disease associated with microscopic polyangiitis and classical polyarteritis nodosa in Kuwait. Nephrol Dial Transplant 1997; 12: 1874-82.
46. Watts RA, Scott DG,. Epidemiology of the vasculitides. Semin Respir Crit Care Med 2004; 25: 455-64.
47. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K,. Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002. Pediatr Int 2006; 48: 356-61.
48. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M,. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009; 48: 1560-5.
49. Yazici H, Fresko I, Yurdakul S,. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3: 148-55.
50. Sakane T, Takeno M, Suzuki N, Inaba G,. Behçet's disease. N Engl J Med 1999; 341: 1284-91.
51. Yurdakul S, Hamuryudan V, Yazici H,. Behçet's syndrome. Curr Opin Rheumatol 2004; 16: 38-42.
52. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet's syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.
53. Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, et al. Mortality in Behçet's disease. Arthritis Rheum 2010; 62: 2806-12.